[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369759-105":59,"doc-detail-369759-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","halofuginone-induces-erk-phosphorylation-and-synergizes-with-trametinib-in-gastric-cancer-cells","Halofuginone induces ERK phosphorylation and synergizes with trametinib in gastric cancer cells","","Study evaluates how halofuginone (HF) affects gastric cancer cells and whether HF combined with trametinib produces synergistic anti-tumor activity. Experiments assess cell viability, apoptosis, and cell cycle, complemented by RNA sequencing with heatmap visualization, and validation using Western blot and qPCR for pro- and anti-apoptotic markers. HF suppresses proliferation, activates ERK phosphorylation, promotes apoptosis, lowers Mcl-1, and strengthens trametinib inhibition while trametinib reduces HF-triggered p-ERK.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/halofuginone-induces-erk-phosphorylation-and-synergizes-with-trametinib-in-gastric-cancer-cells/369759/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/halofuginone-induces-erk-phosphorylation-and-synergizes-with-trametinib-in-gastric-cancer-cells/369759.png","ImageObject",300,407,{"name":92,"@type":93},"supergirl","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the study?","Question",{"text":112,"@type":113},"To determine how halofuginone (HF) impacts gastric cancer cells and whether combining HF with trametinib yields synergistic effects.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do the researchers evaluate the biological effects?",{"text":117,"@type":113},"Cell viability uses the CellTiterGlo assay; apoptosis and cell cycle are assessed via Annexin V-FITC and PI staining, with RNA sequencing, heatmap analysis, and validation by Western blot and qPCR.",{"name":119,"@type":110,"acceptedAnswer":120},"What are the key findings regarding ERK phosphorylation and synergy with trametinib?",{"text":121,"@type":113},"HF inhibits proliferation, induces apoptosis, and increases p-ERK expression. HF and trametinib synergistically inhibit proliferation, while trametinib reduces HF-induced p-ERK.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369759,1790373625,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Original Research Article  \nHalofuginone induces ERK phosphorylation and synergizes with trametinib  \nin gastric cancer cells  \nYuemin Sun*, Peng Wang*, Xiaofeng Bai, Liang Tianand Yuxin Zhong  \nInternational Journal of Immunopathology and Pharmacology Volume 39: 1–11  \n© The Author(s) 2025  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/03946320251359860](DOI: 10.1177/03946320251359860)[ ](DOI: 10.1177/03946320251359860)[journals.sagepub.com/home/iji](journals.sagepub.com/home/iji)  \nAbstract  \nObjective: The aim of this study was to investigate the effects of halofuginone (HF) on gastric cancer cells and whether the combination of HF and trametinib has synergistic effects.  \nIntroduction: Halofuginone, a natural small molecule isolated from the plant Dichroa febrifuga, has been found to have anticancer activity in a variety of cancers, but few studies on HF in gastric cancer.  \nMethods: cell viability was performed using the CellTiterGlo assay and apoptosis and cell cycle analysis was performed by Annexin V-FITC staining and PI staining. We also analyzed RNA sequencing and differentially expressed genes was shown using the heatmap. Western blot and qPCR were carried out to determine the expression of pro-apoptotic and anti-apoptotic proteins.  \nResults: HF inhibited proliferation and induced apoptosis in gastric cancer cells in a dose-dependent manner. HF induced the expression of p-ERK in gastric cancer cells. HF and trametinib synergistically inhibited the gastric cancer cell proliferation. Trametinib inhibited HF-induced p-ERK expression. HF reduced anti-apoptotic protein Mcl-1 expression and reduced trametinib-induced upregulation of Mcl-1 expression.  \nConclusion: HF exerts its anti-cancer effects in gastric cancer and has a synergistic inhibition with trametinib, which may provide a novel therapeutic strategy for gastric cancer.  \nKeywords  \nhalofuginone, gastric cancer, trametinib, p-ERK  \nDate received: 2 February 2025; accepted: 27 June 2025  \nIntroduction  \nGastric cancer is the fifth most common cancer and the third most common cause of cancer death worldwide.1 Traditionally, surgery has been the cornerstone of curative-intent treatment for gastric cancer. However, the realization that gastric cancer is often a systemic disease, even at an earlystage presentation, has led to the development and integration of various systemic treatment modalities, including chemotherapy, targeted therapy, and immunotherapy. The advent of targeted therapies has revolutionized the treatment paradigm for gastric cancer. Trastuzumab, a monoclonal antibody against HER2, as a standard treatment  \noption for HER2-positive gastric cancer, showing a significant survival benefit when combined with chemotherapy.2 Immunotherapy has also emerged  \nDepartment of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China  \n*These authors contributed equally to this work.  \nCorresponding author:  \nYuxin Zhong, Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing 100021, China.  \nEmail: [zhongyuxin@cicams.ac.cn](zhongyuxin@cicams.ac.cn)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use,  \nreproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ([https://us.sagepub.com/en-us/nam/open-a","cbCaiddRPBjwQAv7","https://ap.wps.com/l/cbCaiddRPBjwQAv7","pdf",3562944,11,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Systemic treatment for gastric cancer","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To determine how halofuginone (HF) impacts gastric cancer cells and whether combining HF with trametinib yields synergistic effects.\"},{\"question\":\"How do the researchers evaluate the biological effects?\",\"answer\":\"Cell viability uses the CellTiterGlo assay; apoptosis and cell cycle are assessed via Annexin V-FITC and PI staining, with RNA sequencing, heatmap analysis, and validation by Western blot and qPCR.\"},{\"question\":\"What are the key findings regarding ERK phosphorylation and synergy with trametinib?\",\"answer\":\"HF inhibits proliferation, induces apoptosis, and increases p-ERK expression. HF and trametinib synergistically inhibit proliferation, while trametinib reduces HF-induced p-ERK.\"}]","Halofuginone induces ERK phosphorylation and synergizes with trametinib in gastric cancer cells | PDF",1790184383,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fba62e01d4c3bcca75151a9bfe664b94.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ceb9393ff34a509d89fad7d8b7ff31d4.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53fced1e3d5d490a7ea707aa5a67d5f1.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c188309b8d85f42a1fb5e22c88446e8.webp",980,1306]